Axiom Investors’s LeMaitre Vascular LMAT Stock Holding History

Axiom Investors’s Portfolio LMAT Stock Details LMAT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$6.65M	Buy	69,294 +13,804	+25%	+$1.42M	0.06%	102
2026 Q1	$6.06M	Buy	+55,490	New	+$5.29M	0.07%	97
2017 Q2	–	Sell	-56,554	Closed	-$1.39M	–	153
2017 Q1	$1.39M	Sell	56,554 -152,385	-73%	-$3.58M	0.04%	139
2016 Q4	$5.29M	Buy	208,939 +152,434	+270%	+$3.38M	0.15%	76
2016 Q3	$1.12M	Buy	+56,505	New	+$987K	0.03%	115

Other funds holding LMAT

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

CCA

Conestoga Capital Advisors Wayne, Pennsylvania $4.6B AUM 16.08% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

CAM

Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

CCM

Copeland Capital Management Conshohocken, Pennsylvania $4.87B AUM 31.21% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Axiom Investors's LMAT Position: Q2 2026 in Review

Axiom Investors increased its LeMaitre Vascular (LMAT) stake by 25% in Q2 2026, buying an estimated $1.42M and bringing the position to 69,294 shares worth $6.65M. The position accounts for 0.06% of the portfolio, ranked #102.

Axiom Investors first reported a position in LMAT in Q3 2016 and has held it in 5 quarters since. 326 funds tracked by Wall St. Rank hold LMAT as of Q2 2026.

Axiom Investors held 69,294 shares of LeMaitre Vascular worth $6.65M as of Q2 2026.
Axiom Investors bought 13,804 LeMaitre Vascular shares in Q2 2026, an estimated $1.42M.
LeMaitre Vascular made up 0.06% of Axiom Investors's portfolio in Q2 2026, its #102 holding.
Axiom Investors first reported a position in LeMaitre Vascular in Q3 2016 and has held it in 5 quarters since.
326 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q2 2026.

Based on Axiom Investors's 13F filing for Q2 2026, filed 12 Aug 2026.